Skip to main content
. 2016 Dec 24;19(1):i1–i24. doi: 10.1093/neuonc/now197

Fig. 4.

Fig. 4.

Melanoma mutations.

Mutations in v-Raf murine sarcoma viral oncogene homolog B (BRAF) account for almost half of the driving mutations in melanoma, with another 16% driven by mutations in neuroblastoma RAS viral (v-Ras) oncogene homolog (NRAS).184 Therapies designed to target these mutations have improved outcomes in patients with melanoma.